Jiyeon Oh

home / authors / jiyeon-oh

Jiyeon Oh is a researcher and MD candidate at Kyung Hee University College of Medicine in Seoul, South Korea.

Articles

Why Atopic Dermatitis Treatment is Not “One Size Fits All,” According to Jiyeon Oh

Why Atopic Dermatitis Treatment is Not “One Size Fits All,” According to Jiyeon Oh

Marie Bosslett, Assistant Editor;Jiyeon Oh
April 3rd 2025

Jiyeon Oh’s research confirms that a personalized approach is needed to treat all complexities associated with AD.

Atopic Dermatitis Insights on Global Prevalence, Health Care Implications, and the Impact of COVID-19

Atopic Dermatitis Insights on Global Prevalence, Health Care Implications, and the Impact of COVID-19

Marie Bosslett, Assistant Editor;Jiyeon Oh
April 3rd 2025

Researcher Jiyeon Oh shares results of a recent study that confirm the prevalence of AD is stable, but disease burden is rising.

Latest Updated Articles

2 KOLs are featured in this series.
Published: September 19th 2024 | Updated: September 26th 2024
Final Thoughts: The Importance of Comparative Studies in AD
POLL: What Percent of the Global Population is Estimated to Have Hyperhidrosis?
Published: November 17th 2023 | Updated: April 5th 2025
POLL: What Percent of the Global Population is Estimated to Have Hyperhidrosis?
Journal Digest: February 26
Published: February 26th 2025 | Updated: April 5th 2025
Journal Digest: February 26
POLL: What Treatment Option Do You Most Commonly Use for Patients With Hyperhidrosis?
Published: November 9th 2023 | Updated: April 5th 2025
POLL: What Treatment Option Do You Most Commonly Use for Patients With Hyperhidrosis?
Melinda Gooderham, MD, MSc, FRCPC: Reaffirming Delgocitinib Safety With Minimal Absorption, Maximum Confidence
Published: April 1st 2025 | Updated: April 5th 2025
Melinda Gooderham, MD, MSc, FRCPC: Reaffirming Delgocitinib Safety With Minimal Absorption, Maximum Confidence
Melinda Gooderham, MD, MSc, FRCPC: Minimal Systemic Exposure of Delgocitinib Cream in Chronic Hand Eczema
Published: March 31st 2025 | Updated: April 5th 2025
Melinda Gooderham, MD, MSc, FRCPC: Minimal Systemic Exposure of Delgocitinib Cream in Chronic Hand Eczema
© 2025 MJH Life Sciences

All rights reserved.